In Diabetes Ryzodeg 100IU/ml Penfill contains Insulin degludec, that has a prolonged duration of action as well as insulin aspart, that has a fast onset of action. Together, they ensure rapid and consistent sugar control that helps control blood sugar levels for an entire day. It is given as an injection and your doctor or nurse will train you on the correct way to inject it. Managing blood glucose levels is an essential part of managing diabetes. If you can control the level you will reduce the risk of getting any of the serious complications of diabetes such as kidney damage, eye damage, nerve problems, and loss of limbs. Taking this medicine regularly along with proper diet and exercise will help you live a normal, healthy life.
It is unsafe to consume alcohol with Ryzodeg 100IU/ml Penfill.
Ryzodeg 100IU/ml Penfill may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Information regarding the use of Ryzodeg 100IU/ml Penfill during breastfeeding is not available. Please consult your doctor.
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Ryzodeg 100IU/ml Penfill is safe to use in patients with kidney disease. No dose adjustment of Ryzodeg 100IU/ml Penfill is recommended. However, frequent and regular monitoring of blood glucose levels is advised.
Ryzodeg 100IU/ml Penfill is safe to use in patients with liver disease. No dose adjustment of Ryzodeg 100IU/ml Penfill is recommended. However, frequent and regular monitoring of blood glucose levels is advised.
If you miss a dose of Ryzodeg 100IU/ml Penfill, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More